Zingiber officinale has been used to control lipid disorders and reported to possess remarkable cholesterol-lowering activity in experimental hyperlipidaemia. In the present study, the effect of a characterized and standardized extract of Zingiber officinale on the hepatic lipid levels as well as on the hepatic mRNA and protein expression of low-density lipoprotein (LDL) receptor and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase was investigated in a high-fat diet-fed rat model. Rats were treated with an ethanol extract of Zingiber officinale (400 mg ⁄ kg) extract along with a high-fat diet for 6 weeks. The extract of Zingiber officinale significantly decreased hepatic triglyceride and tended to decrease hepatic cholesterol levels when administered over 6 weeks to the rats fed a high-fat diet. We found that in parallel, the extract up-regulated both LDL receptor mRNA and protein level and down-regulated HMG-CoA reductase protein expression in the liver of these rats. The metabolic control of body lipid homeostasis is in part due to enhanced cholesterol biosynthesis and reduced expression of LDL receptor sites following long-term consumption of high-fat diets. The present results show restoration of transcriptional and post-transcriptional changes in low-density lipoprotein and HMG CoA reductase by Zingiber officinale administration with a high-fat diet and provide a rational explanation for the effect of ginger in the treatment of hyperlipidaemia.Although cholesterol is an essential component of mammalian cell membranes, excess cellular and circulating cholesterol is detrimental and contributes to several life-threatening diseases, including atherosclerotic and coronary artery cardiovascular disease [1,2]. Cellular cholesterol homeostasis is maintained primarily through regulation of the low-density lipoprotein (LDL) receptor and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which respectively affect the uptake and endogenous synthesis of cholesterol in the liver [3][4][5]. A large number of studies have elucidated the role of these regulatory mechanisms in vitro, in experimental animals and in humans treated with experimental diets or drugs [6][7][8]. Recent studies have also shown a regulatory effect of various phyto-ingredients on potential targets controlling in vivo cholesterol homeostasis in animal models treated with atherogenic diets [9][10][11].Zingiber officinale Roscoe (Family: Zingiberaceae) commonly known as 'ginger', is a well-known food spice which has also been used traditionally in a wide variety of ailments [12,13]. The major chemical constituents of ginger rhizome are essential volatile oils and non-volatile pungent compounds [14,15]. The volatile oil components consist mainly of various terpenoids. The non-volatile compounds include the gingerols, shogaols, paradols and zingerone. Among them, the gingerols and shogaols were identified as the major bioactive constituents of ginger, found respectively in fresh and dried ginger [16].In laboratory experiments, e...